Prostatitis

1. Tanner MA, Shoskes D, Shahed A, Pace NR. Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and “nonbacterial” prostatitis. J Clin Microbiol 1999;37:1863–70.

2. Zermann DH, Ishigooka M, Doggweiler R, Schmidt RA. Chronic prostatitis: A myofascial pain syndrome? Infect Urol 1999;12:84–8,92.

3. Lipsky BA. Prostatitis and urinary tract infection in men: what’s new; what’s true? Am J Med 1999;106:327–34 [review].

4. Yavascaoglu I, Oktay B, Simsek U, Ozyurt M. Role of ejaculation in the treatment of chronic non-bacterial prostatitis. Int J Urol 1999;6:130–4.

5. Pakrashi A, Chatterjee S. Effect of tobacco consumption on the function of male accessory sex glands. Int J Androl 1995;18:232–6.

6. Ikeuchi T, Iguchi H. Clinical studies on chronic prostatitis and prostatitis-like syndrome (7). Electric acupuncture therapy for intractable cases of chronic prostatitis-like syndrome. Hinyokika Kiyo 1994;40:587–91 [in Japanese].

7. Evans D. Treatment of chronic abacterial prostatitis: A review. Int J STD AIDS 1994;5:157–64 [review].

8. Nickel JC, Alexander R, Anderson R, et al. Prostatitis unplugged? Prostatic massage revisited. Tech Urol 1999;5:1–7 [review].

9. Lipsky BA. Prostatitis and urinary tract infection in men: what’s new; what’s true? Am J Med 1999;106:327–34 [review].

10. Wenninger K, Heiman JR, Rothman I, et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996;155:965–8.

11. Berghuis JP, Heiman JR, Rothman I, Berger RE. Psychological and physical factors involved in chronic idiopathic prostatitis. J Psychosom Res 1996;41:313–25.

12. Smart CJ, Jenkins JD, Lloyd RS. The painful prostate. Br J Urol 1976;47:861–9.

13. Evans D. Treatment of chronic abacterial prostatitis: A review. Int J STD AIDS 1994;5:157–64 [review].

14. Zermann DH, Ishigooka M, Doggweiler R, Schmidt RA. Chronic prostatitis: A myofascial pain syndrome? Infect Urol 1999;12:84–8,92.

15. Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998;159:883–7.

16. Evans D. Treatment of chronic abacterial prostatitis: A review. Int J STD AIDS 1994;5:157–64 [review].

17. Drach GW. Prostatitis: Man’s hidden infection. Urol Clin North Am 1975;2:499–520 [review].

18. Pizzorno JE, Murray MT. A Textbook of Natural Medicine, 2nd ed. New York: Churchill Livingstone, 1999, 353–4.

19. Pizzorno JE, Murray MT. A Textbook of Natural Medicine, 2nd ed. New York: Churchill Livingstone, 1999, 353–4.

20. Shoskes DA. Use of the bioflavonoid quercetin in patients with longstanding chronic prostatitis. JANA 1999;2:36–9.

21. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999; 54:960–3.

22. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999; 54:960–3.

23. Izaka K, Yamada M, Kawano T, Suyama T. Gastrointestinal absorption and anti-inflammatory effect of bromelain. Jpn J Pharmacol 1972;22:519–34.

24. Shoskes DA. Use of the bioflavonoid quercetin in patients with longstanding chronic prostatitis. JANA 1999;2:36–9.

25. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999; 54:960–3.

26. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999; 54:960–3.

27. Izaka K, Yamada M, Kawano T, Suyama T. Gastrointestinal absorption and anti-inflammatory effect of bromelain. Jpn J Pharmacol 1972;22:519–34.

28. Vidlar A, Vostalova J, Ulrichova J, et al. The effectiveness of dried cranberries (Vaccinium macrocarpon) in men with lower urinary tract symptoms. Br J Nutr 2010;104:1181–90.

29. Buck AC, Rees RW, Ebeling L. Treatment of chronic prostatitis and prostatodynia with pollen extract. Br J Urol 1989;64:496–9.

30. Rugendorff EW, Weidner W, Ebeling L, Buck AC. Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 1993;71:433–8.

31. Jodai A, Maruta N, Shimomae E, et al. A long-term therapeutic experience with Cernilton in chronic prostatitis. Hinyokika Kiyo 1988;34:561–8 [in Japanese].

32. Suzuki T, Kurokawa K, Mashimo T, et al. Clinical effect of Cernilton in chronic prostatitis. Hinyokika Kiyo 1992;38:489–94 [in Japanese].

33. Ohkoshi M, Kawamura N, Nagakubo I. Clinical evaluation of Cernilton in chronic prostatitis. Jpn J Clin Urol 1967;21:73–6.

34. Pizzorno JE, Murray MT. A Textbook of Natural Medicine, 2nd ed.. New York: Churchill Livingstone, 1999, 968.

35. Anesini C, Perez C. Screening of plants used in Argentine folk medicine for antimicrobial activity. J Ethnopharmacol 1993;39:119–28.

36. Carani C, Salvioli V, Scuteri A, et al. Urological and sexual evaluation of treatment of benign prostatic disease using Pygeum africanum at high doses. Arch Ital Urol Nefrol Androl 1991;63:341–5 [in Italian].

37. Menchini-Fabris GF, Giorgi P, Andreini F, et al. New perspectives on treatment of prostato-vesicular pathologies with Pygeum Africanum. Arch It Urol 1988;LX:313–22 [in Italian].

38. Felter HW, Lloyd JU. Kings American Dispensatory, Vol II. Portland, OR: Eclectic Medical Publications, 1983, 1751–2.

39. Breu W, Hagenlocher M, Redl K, et al. [Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism]. Arzneimittelforschung 1992;42:547–51 [in German].

40. Sirsi M. Antimicrobial action of vitamin C on M.tuberculosis and some other pathogenic organisms. Indian J Med Sci 1952;6:252–5.

41. Axelrod DR. Ascorbic acid and urinary pH. JAMA 1985;254:1310–1 [letter].

42. Lundberg JO, Carlsson S, Engstrand L, et al. Urinary nitrite: more than a marker of infection. Urology 1997;50:189–91.

43. Colleen S, Mardh PA, Schytz A. Magnesium and zinc in seminal fluid of healthy males and patients with non-acute prostatitis with and without gonorrhoea. Scand J Urol Nephrol 1975;9:192–7.

44. Fair WR, Parrish RF. Antibacterial substances in prostatic fluid. Prog Clin Biol Res 1981;75A:247–64.

45. Lipsky BA. Prostatitis and urinary tract infection in men: what’s new; what’s true? Am J Med 1999;106:327–34 [review].

46. Colleen S, Mardh PA, Schytz A. Magnesium and zinc in seminal fluid of healthy males and patients with non-acute prostatitis with and without gonorrhoea. Scand J Urol Nephrol 1975;9:192–7.

47. Fair WR, Couch J, Wehner N. Prostatic antibacterial factor. Identity and significance. Urology 1976;7:169–77.

48. Kavanagh JP, Darby C, Costello CB. The response of seven prostatic fluid components to prostatic disease. Int J Androl 1982;5:487–96.

49. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ. Semen zinc levels in infertile and postvasectomy patients and patients with prostatitis. Fertil Steril 1975;26:1057–63.

50. Lipsky BA. Prostatitis and urinary tract infection in men: what’s new; what’s true? Am J Med 1999;106:327–34 [review].

51. Neal DE Jr, Kaack MB, Fussell EN, Roberts JA. Changes in seminal fluid zinc during experimental prostatitis. Urol Res 1993;21:71–4.

52. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ. Semen zinc levels in infertile and postvasectomy patients and patients with prostatitis. Fertil Steril 1975;26:1057–63.

53. Fair WR, Couch J, Wehner N. Prostatic antibacterial factor. Identity and significance. Urology 1976;7:169–77.

54. Bush IM, Berman E, Nourkayhan S, et al. Zinc and the prostate. Presented at the annual meeting of the American Medical Association Chicago, 1974.